Insufficient scRNA-seq data for expression of ELF5 at single-cell level.
Insufficient scRNA-seq data for expression of ELF5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 73% | 244.85 | 179 / 245 | 72% | 6.12 | 363 / 502 |
| bladder | 71% | 601.71 | 15 / 21 | 56% | 8.40 | 283 / 504 |
| lung | 68% | 372.11 | 392 / 578 | 54% | 5.74 | 621 / 1155 |
| breast | 60% | 2296.20 | 277 / 459 | 61% | 26.90 | 681 / 1118 |
| kidney | 91% | 512.55 | 81 / 89 | 2% | 0.12 | 14 / 901 |
| skin | 68% | 497.23 | 1237 / 1809 | 2% | 0.15 | 8 / 472 |
| esophagus | 21% | 32.14 | 310 / 1445 | 20% | 1.60 | 37 / 183 |
| pancreas | 13% | 18.86 | 44 / 328 | 25% | 1.86 | 44 / 178 |
| uterus | 1% | 3.46 | 2 / 170 | 31% | 4.15 | 144 / 459 |
| spleen | 32% | 45.82 | 77 / 241 | 0% | 0 | 0 / 0 |
| stomach | 7% | 6.65 | 26 / 359 | 20% | 2.17 | 56 / 286 |
| intestine | 0% | 0.19 | 1 / 966 | 19% | 1.67 | 99 / 527 |
| tonsil | 0% | 0 | 0 / 0 | 18% | 0.83 | 8 / 45 |
| thymus | 0% | 0.52 | 3 / 653 | 3% | 0.32 | 16 / 605 |
| adipose | 3% | 12.09 | 34 / 1204 | 0% | 0 | 0 / 0 |
| ovary | 1% | 0.52 | 1 / 180 | 1% | 0.06 | 6 / 430 |
| brain | 0% | 0.20 | 5 / 2642 | 1% | 0.02 | 4 / 705 |
| muscle | 0% | 1.13 | 4 / 803 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 0% | 0.04 | 2 / 406 |
| adrenal gland | 0% | 2.86 | 1 / 258 | 0% | 0 | 0 / 230 |
| blood vessel | 0% | 0.33 | 2 / 1335 | 0% | 0 | 0 / 0 |
| heart | 0% | 0.86 | 1 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0.20 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0030154 | Biological process | cell differentiation |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| Gene name | ELF5 |
| Protein name | ETS-related transcription factor Elf-5 (E74-like factor 5) (Epithelium-restricted ESE-1-related Ets factor) (Epithelium-specific Ets transcription factor 2) (ESE-2) E74 like ETS transcription factor 5 E74-like factor 5 (Ets domain transcription factor), isoform CRA_a (cDNA FLJ78106, highly similar to Homo sapiens E74-like factor 5 (ets domain transcription factor) (ELF5), transcript variant 2, mRNA) (cDNA FLJ90716 fis, clone PLACE1008549, highly similar to ETS-related transcription factor Elf-5) (cDNA, FLJ92906, Homo sapiens E74-like factor 5 (ets domain transcription factor)(ELF5), mRNA) |
| Synonyms | ESE2 hCG_28585 |
| Description | FUNCTION: Transcriptionally activator that may play a role in regulating the later stages of keratinocytes terminal differentiation. .; FUNCTION: Isoform 2 binds to DNA sequences containing the consensus nucleotide core sequence GGA[AT]. Transcriptionally activates SPRR2A and the parotid gland-specific PSP promoters. . |
| Accessions | ENST00000257832.7 [Q9UKW6-2] A0A087X1W9 ENST00000429939.6 [Q9UKW6-4] ENST00000673820.1 ENST00000532417.1 [Q9UKW6-3] A8K443 ENST00000620316.4 A0A669KB78 ENST00000312319.6 [Q9UKW6-1] Q9UKW6 |